These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4570750)

  • 1. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate in tardive dyskinesia.
    Fann WE; Davis JM; Wilson IC
    Am J Psychiatry; 1973 Aug; 130(8):922-4. PubMed ID: 4577471
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive and withdrawal dyskinesia associated with haloperidol.
    Jacobson G; Baldessarini RJ; Manschreck T
    Am J Psychiatry; 1974 Aug; 131(8):910-3. PubMed ID: 4834709
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tardive dyskinesia. Synthetic-critical review and case contribution].
    Campanini T; Catalano A; De Risio C; Forino V
    Ateneo Parmense Acta Biomed; 1977; 48(1):41-60. PubMed ID: 324489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].
    Schumm F; Dichgans J; Zeller E
    Arch Psychiatr Nervenkr (1970); 1981; 230(4):315-23. PubMed ID: 7316728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
    Pakkenberg H; Fog R
    Arch Neurol; 1974 Nov; 31(5):352-3. PubMed ID: 4607088
    [No Abstract]   [Full Text] [Related]  

  • 12. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS; Wodak J; Veale JL; Munro OR
    Med J Aust; 1972 Nov; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention and management of tardive dyskinesia.
    Crane GE
    Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H; Cole JO
    Arch Gen Psychiatry; 1972 Dec; 27(6):824-7. PubMed ID: 4637899
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J; Thorsen K; Munkvad I
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia: side effect or not?
    Curran JP
    Am J Psychiatry; 1973 Apr; 130(4):406-10. PubMed ID: 4144163
    [No Abstract]   [Full Text] [Related]  

  • 17. Tardive dyskinesia.
    Schiele BC; Gallant D; Simpson G; Gardner EA; Cole JO
    Am J Orthopsychiatry; 1973 Jul; 43(4):506 passim. PubMed ID: 4716664
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG; Breden EL
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
    Tobias LL; MacDonald ML
    Psychol Bull; 1974 Feb; 81(2):107-25. PubMed ID: 4149623
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of tardive dyskinesia with thiopropazate.
    Curran JP
    Am J Psychiatry; 1973 Aug; 130(8):925-7. PubMed ID: 4146097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.